These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 4765368)

  • 41. Cytophilic activity associated with murine allogeneic tumor rejection.
    Mazzolli AB; Barrera CN; Colmerauer ME; Pasqualini CD
    Medicina (B Aires); 1978; 38(6 Pt 1):639-42. PubMed ID: 374929
    [No Abstract]   [Full Text] [Related]  

  • 42. Enhancement of normal lymphocyte cytotoxicity by sera with high antibody titers against H-2 or virus-associated antigens.
    Harada M; Pearson G; Pettigrew H; Redmon L; Orr T
    Cancer Res; 1973 Nov; 33(11):2886-93. PubMed ID: 4583975
    [No Abstract]   [Full Text] [Related]  

  • 43. In vitro demonstration of tumor-specific common antigens and embryonal antigens in murine fibrosarcomas induced by 7,12-dimethylbenz(a)anthracene.
    Ménard S; Colnaghi MI; Della Porta G
    Cancer Res; 1973 Mar; 33(3):478-81. PubMed ID: 4689897
    [No Abstract]   [Full Text] [Related]  

  • 44. In vivo and in vitro studies of the influence of the immune status of C3Hf-Bu mice on the effectiveness of local irradiation of a methylcholanthrene-induced fibrosarcoma.
    Jurin M; Suit HD
    Cancer Res; 1972 Oct; 32(10):2201-11. PubMed ID: 5080765
    [No Abstract]   [Full Text] [Related]  

  • 45. Enhanced immune reactivity to hepatoma 22a cells in MTV-infected compared with MTV-free C3H mice.
    Lavrovsky VA; Viksler VK
    Immunology; 1981 Dec; 44(4):671-6. PubMed ID: 6274791
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Transplantable ascitic tumor derived from a mouse with moloney sarcoma: tumorigenic, antigenic and virologic properties (author's transl)].
    Weiland E; Weiland F
    Z Immunitatsforsch Exp Klin Immunol; 1974 Nov; 148(2):151-61. PubMed ID: 4283271
    [No Abstract]   [Full Text] [Related]  

  • 47. CD4+ T lymphocytes play a critical role in antibody production and tumor immunity against simian virus 40 large tumor antigen.
    Kennedy RC; Shearer MH; Watts AM; Bright RK
    Cancer Res; 2003 Mar; 63(5):1040-5. PubMed ID: 12615720
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunoprophylaxis of transplantable methylcholanthrene-induced murine fibrosarcomas by immunization with embryo cells expressing endogenous murine leukemia virus antigens.
    Zbar B; Manohar V; Sugimoto T; Ashley MP; Kato Y; Rappaport P
    Cancer Res; 1981 Nov; 41(11 Pt 1):4499-507. PubMed ID: 6272979
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Studies on immunity to autochthonous mouse tumors.
    Hellström I; Hellström KE; Pierce GE; Fefer A
    Transplant Proc; 1969 Mar; 1(1):90-4. PubMed ID: 5406848
    [No Abstract]   [Full Text] [Related]  

  • 50. Tumor immunity and the mechanism of polyinosinic-polycytidylic acid inhibition of tumor growth.
    Kreider JW; Benjamin SA
    J Natl Cancer Inst; 1972 Nov; 49(5):1303-10. PubMed ID: 4568087
    [No Abstract]   [Full Text] [Related]  

  • 51. Regression of feline sarcoma virus-induced sarcomas in dogs. II. Immunologic investigations.
    Slauson DO; Osburn BI; Shifrine M; Dungworth DL
    J Natl Cancer Inst; 1975 Feb; 54(2):371-7. PubMed ID: 46276
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The role of host lymphoid populations in the response of mouse EMT6 tumor to photodynamic therapy.
    Korbelik M; Krosl G; Krosl J; Dougherty GJ
    Cancer Res; 1996 Dec; 56(24):5647-52. PubMed ID: 8971170
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lectin potentiation of BCG-contact-mediated antitumor action.
    Poduval TB; Seshadri M; Sundaram K
    J Natl Cancer Inst; 1980 Nov; 65(5):909-12. PubMed ID: 6933260
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The role of adherent cells in tumor immunity.
    Burk MW; Yu S; McKhann CF
    Surg Forum; 1975; 26():140-2. PubMed ID: 1216090
    [No Abstract]   [Full Text] [Related]  

  • 55. In vivo analysis of the 'bystander effect': a cytokine cascade.
    Ramesh R; Marrogi AJ; Munshi A; Abboud CN; Freeman SM
    Exp Hematol; 1996 Jun; 24(7):829-38. PubMed ID: 8647234
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Regulation of cell-mediated immunologic reactivity to Moloney Murine sarcoma virus-induced tumors. III. Further characterization of tumor-specific serum blocking factors.
    Halliday WJ; Koppi TA; McKenzie IF
    J Natl Cancer Inst; 1982 Oct; 69(4):939-44. PubMed ID: 6750199
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Specificity of in vivo tumor rejection assessed by mixing immune spleen cells with target and unrelated tumor cells.
    Röllinghoff M; Warner NL
    Proc Soc Exp Biol Med; 1973 Dec; 144(3):813-8. PubMed ID: 4543620
    [No Abstract]   [Full Text] [Related]  

  • 58. [Histocompatibility antigens of 2 transplantable reticulum cell tumors TRH 3 and TRBL 3 (induced in BALB/c/Cb/Se and C57BL/Cb/Se mice with ascites mammary carcinoma ATPC+). I. Transplantability tests].
    Maltzeff N
    Lav Ist Anat Istol Patol Univ Studi Perugia; 1975; 35(1):29-41. PubMed ID: 1243772
    [No Abstract]   [Full Text] [Related]  

  • 59. Selection and rejection of retrovirus-expressing tumor cells from a heterogeneous murine leukemia virus-infected cell population.
    Zbar B; Terata N; Nagai A; Tanio Y; Hovis J
    Cancer Res; 1984 Oct; 44(10):4622-9. PubMed ID: 6088041
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The role of T cells in allografted tumor rejection: IFN-gamma released from T cells is essential for induction of effector macrophages in the rejection site.
    Yoneda Y; Yoshida R
    J Immunol; 1998 Jun; 160(12):6012-7. PubMed ID: 9637516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.